Modified Texture Diets in Oropharyngeal Dysphagia: An Evidence–Ethics Mismatch and a Research Agenda

Abstract

Modified texture diets (MTDs), thickened liquids and texture-altered foods, are the dominant interventions offered by speech and language therapists for oropharyngeal dysphagia, and their use rests on the long-held assumption that reducing aspiration reduces aspiration pneumonia. Three bodies of evidence have matured largely in parallel but are rarely brought together: the efficacy literature for MTDs in pneumonia prevention, the literature on their iatrogenic harms, and the emerging empirical literature on informed consent for their prescription. This integrative narrative review synthesises these three strands. Randomised trial and observational evidence do not support a reliable pneumonia prevention benefit, and a 2024 matched cohort study of nearly 9,000 hospitalised patients with dementia found no mortality advantage and a higher rate of respiratory complications in the thick liquids group. Concurrently, MTDs are consistently associated with reduced fluid and nutrient intake, altered medication bioavailability, poorer quality of life, and reduced mealtime satisfaction. Against this backdrop, recent survey evidence indicates that most clinicians cannot fully list the known harms of MTDs, and fewer than half report routinely disclosing those harms to patients before prescription. Read together, the three strands describe an evidence, ethics mismatch: a high volume intervention of uncertain benefit and documented harm is being delivered without meaningful informed consent. Closing this gap will require patient facing empirical work on understanding and recall, trials of structured consent tools, qualitative research on the institutional drivers of under-disclosure, and cross-cultural work on consent in settings where autonomy, family, and food culture interact differently.